Anti-Leishmania infantum IgG Antibody Avidity in Visceral Leishmaniasis


Autoria(s): Tiburcio, Monique Gomes Salles; Anversa, Laís; Kanunfre, Kelly Aparecida; Ferreira, Antonio Walter; Rodrigues Júnior, Virmondes; Silva, Luciana de Almeida
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

24/03/2014

24/03/2014

24/03/2014

Resumo

IgG avidity tests are used to discriminate acute from chronic infections. There are few reports on the IgG avidity profile of patients with visceral leishmaniasis (VL). This study investigated the anti-Leishmania IgG avidity in patients with classic VL (n = 10), patients showing clinical cure after treatment (n = 18), and asymptomatic subjects with at least one positive Leishmania test (n = 20). All subjects were from areas in Brazil where VL is endemic. Serum samples were collected from each subject on two different occasions. IgG avidity was evaluated by Western blotting. The proportion of high-avidity antibodies was higher in all samples from patients with classic VL. In contrast, low-avidity antibodies predominated in subjects with a history of VL, including 13 cases (72.2%) in the first assessment and 14 (77.8%) in the second. Fifteen (75%) of the asymptomatic subjects presented a predominance of low-avidity antibodies in the first assessment, and the frequency of high-avidity antibodies increased over time in seven subjects (35%) of this group. Antibodies against the 14- and/or 16-kDa antigen fraction were detected in the first assessment in all patients with classic VL, in 10 (55.5%) treated patients, and in 10 (50%) asymptomatic subjects. These were high-avidity antibodies in most cases. In the asymptomatic group, an increase in IgG avidity against the 14- and/or 16-kDa antigen fraction was observed in three cases (15%). The results indicate distinct responses in infected and asymptomatic subjects, probably associated with the length of time after infection. In this respect, IgG avidity tests represent a new approach to better characterize asymptomatic VL.

Identificador

Clinical and Vaccine Immunology, v. 20, n. 11, p. 1697-1702, 2013.

http://www.producao.usp.br/handle/BDPI/44252

10.1128/CVI.00367-13

http://cvi.asm.org/content/20/11/1697.full.pdf+html

Idioma(s)

eng

Publicador

Washington, DC.

Relação

Clinical and Vaccine Immunology

Direitos

restrictedAccess

American Society for Microbiology

Palavras-Chave #Anti-Leishmania infantum #Leishmania visceral
Tipo

article

original article

publishedVersion